Last reviewed · How we verify
Testogel 1%
Testogel 1% is a topical testosterone gel used to treat hypogonadism in males.
Testogel 1% is a topical testosterone gel used to treat hypogonadism in males. Used for Treatment of hypogonadism in males.
At a glance
| Generic name | Testogel 1% |
|---|---|
| Sponsor | Laboratoires Besins International |
| Drug class | Androgen replacement therapy |
| Target | Androgen receptor |
| Modality | Small molecule |
| Therapeutic area | Urology |
| Phase | Phase 3 |
Mechanism of action
Testosterone replacement therapy with Testogel 1% aims to restore normal testosterone levels in men with hypogonadism, which can lead to symptoms such as low libido, fatigue, and decreased muscle mass. The gel is applied topically to the skin, allowing for controlled release of testosterone into the bloodstream.
Approved indications
- Treatment of hypogonadism in males
Common side effects
- Application site reactions
- Skin irritation
- Allergic reactions
Key clinical trials
- Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality (PHASE2)
- Study of The Effects of Testosterone in Frail Elderly Men (PHASE4)
- Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity
- Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM) (PHASE3)
- Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients
- Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism (PHASE3)
- Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism (NA)
- Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Testogel 1% CI brief — competitive landscape report
- Testogel 1% updates RSS · CI watch RSS
- Laboratoires Besins International portfolio CI